These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38510846)

  • 1. Young infant clinical signs study--, Pakistan: a data note.
    Shahid S; Tikmani SS; Brown N; Zaidi AKM; Jehan F; Nisar MI
    Gates Open Res; 2021; 5():122. PubMed ID: 38510846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical signs that predict severe illness in children under age 2 months: a multicentre study.
    Young Infants Clinical Signs Study Group
    Lancet; 2008 Jan; 371(9607):135-42. PubMed ID: 18191685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of possible serious bacterial infection in young infants where referral is not possible in the context of existing health system structure in Ibadan, South-west Nigeria.
    Ayede AI; Ashubu OO; Fowobaje KR; Aboubaker S; Nisar YB; Qazi SA; Bahl R; Falade AG
    PLoS One; 2021; 16(3):e0248720. PubMed ID: 33784321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral amoxicillin plus gentamicin regimens may be superior to the procaine-penicillin plus gentamicin regimens for treatment of young infants with possible serious bacterial infection when referral is not feasible: Pooled analysis from three trials in Africa and Asia.
    Longombe AL; Ayede AI; Marete I; Mir F; Ejembi CL; Shahidullah M; Adejuyigbe EA; Wammanda RD; Tshefu A; Esamai F; Zaidi AK; Baqui AH; Cousens S
    J Glob Health; 2022 Nov; 12():04084. PubMed ID: 36403158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical signs predictive of severe illness in young Pakistani infants.
    Shahid S; Tikmani SS; Nayani K; Munir A; Brown N; Zaidi AKM; Jehan F; Nisar MI
    BMC Res Notes; 2021 Feb; 14(1):71. PubMed ID: 33627174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial.
    Mir F; Nisar I; Tikmani SS; Baloch B; Shakoor S; Jehan F; Ahmed I; Cousens S; Zaidi AK
    Lancet Glob Health; 2017 Feb; 5(2):e177-e185. PubMed ID: 27988146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation research on management of sick young infants with possible serious bacterial infection when referral is not possible in Jimma Zone, Ethiopia: Challenges and solutions.
    Berhane M; Girma T; Tesfaye W; Jibat N; Abera M; Abrahim S; Aboubaker S; Nisar YB; Ahmad Qazi S; Bahl R; Abdissa A
    PLoS One; 2021; 16(8):e0255210. PubMed ID: 34370744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified antibiotic regimens for young infants with possible serious bacterial infection when the referral is not feasible in the Democratic Republic of the Congo.
    Lokangaka A; Ishoso D; Tshefu A; Kalonji M; Takoy P; Kokolomami J; Otomba J; Aboubaker S; Qazi SA; Nisar YB; Bahl R; Bose C; Coppieters Y
    PLoS One; 2022; 17(6):e0268277. PubMed ID: 35771738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial.
    ; Tshefu A; Lokangaka A; Ngaima S; Engmann C; Esamai F; Gisore P; Ayede AI; Falade AG; Adejuyigbe EA; Anyabolu CH; Wammanda RD; Ejembi CL; Ogala WN; Gram L; Cousens S
    Lancet; 2015 May; 385(9979):1767-1776. PubMed ID: 25842221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How long should young infants less than two months of age with moderate-mortality-risk signs of possible serious bacterial infection be hospitalised for? Study protocol for a randomised controlled trial from low- and middle-income countries.
    PSBI Study Group
    J Glob Health; 2023 Jul; 13():04056. PubMed ID: 37448340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical signs of possible serious infection and associated mortality among young infants presenting at first-level health facilities.
    Nisar YB; Tshefu A; Longombe AL; Esamai F; Marete I; Ayede AI; Adejuyigbe EA; Wammanda RD; Qazi SA; Bahl R
    PLoS One; 2021; 16(6):e0253110. PubMed ID: 34191832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative approach for potential scale-up to jump-start simplified management of sick young infants with possible serious bacterial infection when a referral is not feasible: Findings from implementation research.
    Leul A; Hailu T; Abraham L; Bayray A; Terefe W; Godefay H; Fantaye M; Qazi SA; Aboubaker S; Nisar YB; Bahl R; Tekle E; Mulugeta A
    PLoS One; 2021; 16(2):e0244192. PubMed ID: 33544712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile and predictors of severe illness in young South African infants (<60 days).
    Jeena PM; Adhikari M; Carlin JB; Qazi S; Weber MW; Hamer DH
    S Afr Med J; 2008 Nov; 98(11):883-8. PubMed ID: 19177896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ongoing trials of simplified antibiotic regimens for the treatment of serious infections in young infants in South Asia and sub-Saharan Africa: implications for policy.
    Esamai F; Tshefu AK; Ayede AI; Adejuyigbe EA; Wammanda RD; Baqui AH; Zaidi AK; Saha S; Rollins NC; Wall S; Brandes N; Engmann C; Darmstadt G; Qazi SA; Bahl R
    Pediatr Infect Dis J; 2013 Sep; 32 Suppl 1(Suppl 1 Innovative Treatment Regimens for Severe Infections in Young Infants):S46-9. PubMed ID: 23945576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age.
    Puri D; Nisar YB; Tshefu A; Longombe AL; Esamai F; Marete I; Ayede AI; Adejuyigbe EA; Wammanda RD; Qazi SA; Bahl R
    PLoS One; 2021; 16(2):e0247457. PubMed ID: 33626090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical signs predicting severe illness in young infants (<60 days) in Bolivia.
    Mazzi E; Bartos AE; Carlin J; Weber MW; Darmstadt GL;
    J Trop Pediatr; 2010 Oct; 56(5):307-16. PubMed ID: 20144933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal place of treatment for young infants aged less than two months with any low-mortality-risk sign of possible serious bacterial infection: Study Protocol for a randomised controlled trial from low- and middle-income countries.
    PSBI Study Group
    J Glob Health; 2023 Jul; 13():04055. PubMed ID: 37449353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying sick children requiring referral to hospital in Bangladesh.
    Kalter HD; Schillinger JA; Hossain M; Burnham G; Saha S; de Wit V; Khan NZ; Schwartz B; Black RE
    Bull World Health Organ; 1997; 75 Suppl 1(Suppl 1):65-75. PubMed ID: 9529719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious aetiologies of neonatal illness in south Asia classified using WHO definitions: a primary analysis of the ANISA study.
    Arvay ML; Shang N; Qazi SA; Darmstadt GL; Islam MS; Roth DE; Liu A; Connor NE; Hossain B; Sadeq-Ur Rahman Q; El Arifeen S; Mullany LC; Zaidi AKM; Bhutta ZA; Soofi SB; Shafiq Y; Baqui AH; Mitra DK; Panigrahi P; Panigrahi K; Bose A; Isaac R; Westreich D; Meshnick SR; Saha SK; Schrag SJ
    Lancet Glob Health; 2022 Sep; 10(9):e1289-e1297. PubMed ID: 35961352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.